Therapeutic vaccination for the elimination of HPV16+ high-grade dysplasia: A phase I clinical trial of the DNA vaccine pNGVL4aCRTE6E7L2, administered via the TriGrid™ electroporation device
Year: 2024
Type: article
Source: Gynecologic Oncology
Authors: Kimberly Levinson, Rebecca Arend, Benjamin Matthews, Tullia Rushton, Alfonsus Adrian Harsono, Hao Wang, Sejong Bae, Darin Ostrander, Karen Horner, Ashish Solanki, Alexis Peay, Stephanie Clevenger, Anna Wilbanks, Angelica Therese Gales, Chien-Fu Hung, Y.C. Tsai, Bailee Dover, Jennah Moore, Peter Ketch, Kaitlyn Kincaid, Donna Dunn, Charles Leath, T.C. Wu, Warner Huh, Richard Roden
Institutions: Johns Hopkins Medicine, University of Alabama at Birmingham
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4403254230